• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter: serum hepatitis B virus DNA and risk of hepatocellular carcinoma in patients with chronic hepatitis B.

作者信息

Huang Rui, Liu Jiacheng, Wang Jian, Yan Xiaomin, Wu Chao

机构信息

Department of Infectious Diseases, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.

Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.

出版信息

Aliment Pharmacol Ther. 2021 Mar;53(6):761-762. doi: 10.1111/apt.16264.

DOI:10.1111/apt.16264
PMID:33599329
Abstract
摘要

相似文献

1
Letter: serum hepatitis B virus DNA and risk of hepatocellular carcinoma in patients with chronic hepatitis B.信函：慢性乙型肝炎患者血清乙肝病毒DNA与肝细胞癌风险
Aliment Pharmacol Ther. 2021 Mar;53(6):761-762. doi: 10.1111/apt.16264.
2
Letter: serum hepatitis B virus DNA and risk of hepatocellular carcinoma in patients with chronic hepatitis B-authors' reply.信函：慢性乙型肝炎患者血清乙肝病毒DNA与肝细胞癌风险——作者回复
Aliment Pharmacol Ther. 2021 Mar;53(6):763. doi: 10.1111/apt.16278.
3
Letter to the editor: Hepatitis B virus genotype: A significant risk factor in determining which patients with chronic hepatitis B virus infection should undergo surveillance for hepatocellular carcinoma: The hepatitis B Alaska study.
Hepatology. 2022 Sep;76(3):E63-E64. doi: 10.1002/hep.32544. Epub 2022 May 11.
4
Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B.信件：慢性乙型肝炎免疫耐受期肝细胞癌的风险
Aliment Pharmacol Ther. 2020 Sep;52(5):911-912. doi: 10.1111/apt.15966.
5
Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B-authors' reply.信函：慢性乙型肝炎免疫耐受期肝细胞癌的风险——作者回复
Aliment Pharmacol Ther. 2020 Sep;52(5):913-914. doi: 10.1111/apt.15992.
6
[Effect of chronic hepatitis B virus DNA negative transformation and HBsAg clearance on the occurrence of hepatocellular carcinoma].[慢性乙型肝炎病毒DNA转阴及HBsAg清除对肝细胞癌发生的影响]
Zhonghua Gan Zang Bing Za Zhi. 2019 Nov 20;27(11):831-833. doi: 10.3760/cma.j.issn.1007-3418.2019.11.004.
7
Natural history of chronic hepatitis B REVEALed.慢性乙型肝炎的自然史被揭示。
J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x.
8
Reply to 'Consider more about risk scores for predicting hepatocellular carcinoma in patients with chronic hepatitis B'-A reply.对《关于慢性乙型肝炎患者肝细胞癌预测风险评分的更多思考》的回复——一篇回复
J Viral Hepat. 2021 Oct;28(10):1502. doi: 10.1111/jvh.13567. Epub 2021 Jul 10.
9
Natural history of chronic hepatitis B: extending the REVEAL study.慢性乙型肝炎的自然史：拓展REVEAL研究
Liver Int. 2010 Sep;30(8):1085-6. doi: 10.1111/j.1478-3231.2010.02277.x. Epub 2010 May 21.
10
Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma.
Aliment Pharmacol Ther. 2016 Jul;44(2):210-1. doi: 10.1111/apt.13674.